CASRN: 359-83-1
Drug Levels and Effects
Summary of Use during Lactation
No information is available on the use of pentazocine during breastfeeding. Maternal use of oral opioids during breastfeeding can cause infant drowsiness, which may progress to rare but severe central nervous system depression. Newborn infants seem to be particularly sensitive to the effects of even small dosages of narcotic analgesics. If pentazocine is required by the mother of a newborn, it is not a reason to discontinue breastfeeding; however, once the mother's milk comes in, it is best to provide pain control with a nonnarcotic analgesic and limit maternal intake of pentazocine to 2 to 3 days at a low dosage with close infant monitoring. If the baby shows signs of increased sleepiness (more than usual), difficulty breastfeeding, breathing difficulties, or limpness, a physician should be contacted immediately. Other agents are preferred over pentazocine during breastfeeding.[1]
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Pentazocine can increase serum prolactin.[2,3] However, the prolactin level in a mother with established lactation may not affect her ability to breastfeed.
Alternate Drugs to Consider
Acetaminophen, Butorphanol, Hydromorphone, Ibuprofen, Morphine
References
- 1.
- Sachs, HC, The Committee on Drugs. The transfer of drugs and therapeutics into human breast milk: An update on selected topics [Reaffirmed May, 2018]. Pediatrics 2013;132:e796-809. [PubMed: 23979084]
- 2.
- Rolandi E, Barreca T. Effects of two analgesic opiates (methadone and pentazocine) on the serum prolactin levels in breast cancer. Acta Endocrinol (Copenh) 1978;88:452-4. [PubMed: 581016]
- 3.
- Manner T, Kanto J, Scheinin H, et al. Meptazinol and pentazocine: Effects on prolactin, growth hormone and vasopressin levels in plasma. Pharmacol Toxicol 1987;61:301-4. [PubMed: 3438224]
Substance Identification
Substance Name
Pentazocine
CAS Registry Number
359-83-1
Drug Class
Breast Feeding
Lactation
Milk, Human
Analgesics, Opioid
Narcotics
Narcotic Antagonists
Opiates
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
Publication Details
Publication History
Last Revision: December 15, 2023.
Copyright
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Publisher
National Institute of Child Health and Human Development, Bethesda (MD)
NLM Citation
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-. Pentazocine. [Updated 2023 Dec 15].